USD 1.75
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 170.01 Million AUD | 1.49% |
2023 | 167.51 Million AUD | 39.91% |
2022 | 119.72 Million AUD | 17.57% |
2021 | 101.83 Million AUD | 2.47% |
2020 | 99.38 Million AUD | 18.22% |
2019 | 84.06 Million AUD | 38.61% |
2018 | 60.64 Million AUD | -10.16% |
2017 | 67.5 Million AUD | 57.74% |
2016 | 42.79 Million AUD | 92.65% |
2015 | 22.21 Million AUD | 3.36% |
2014 | 21.49 Million AUD | 44.25% |
2013 | 14.89 Million AUD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 FY | 171.56 Million AUD | 2.42% |
2024 Q4 | 45.18 Million AUD | 0.0% |
2024 Q1 | 39.81 Million AUD | -53.55% |
2024 Q2 | 80.65 Million AUD | 102.54% |
2024 Q3 | 45.18 Million AUD | -43.97% |
2023 Q2 | 81.79 Million AUD | 100.57% |
2023 Q4 | 85.71 Million AUD | 103.06% |
2023 Q1 | 40.78 Million AUD | -32.47% |
2023 FY | 167.51 Million AUD | 39.91% |
2023 Q3 | 42.21 Million AUD | -48.39% |
2022 Q2 | 59.34 Million AUD | 95.69% |
2022 Q4 | 60.38 Million AUD | 102.39% |
2022 FY | 119.72 Million AUD | 17.57% |
2022 Q1 | 30.32 Million AUD | -48.33% |
2022 Q3 | 29.83 Million AUD | -49.72% |
2021 FY | 101.83 Million AUD | 2.47% |
2021 Q3 | 29.96 Million AUD | -30.55% |
2021 Q4 | 58.68 Million AUD | 95.83% |
2021 Q1 | 21.57 Million AUD | -58.13% |
2021 Q2 | 43.14 Million AUD | 100.0% |
2020 Q4 | 51.52 Million AUD | 100.0% |
2020 FY | 99.38 Million AUD | 18.22% |
2020 Q1 | 24.26 Million AUD | 11.22% |
2020 Q2 | 48.52 Million AUD | 100.0% |
2020 Q3 | 25.76 Million AUD | -46.91% |
2019 Q4 | 21.81 Million AUD | 0.0% |
2019 Q1 | 20.34 Million AUD | 32.6% |
2019 Q2 | 20.34 Million AUD | 0.0% |
2019 Q3 | 21.81 Million AUD | 7.22% |
2019 FY | 84.06 Million AUD | 38.61% |
2018 Q3 | 15.34 Million AUD | 2.27% |
2018 FY | 60.64 Million AUD | -10.16% |
2018 Q1 | 15 Million AUD | -4.39% |
2018 Q2 | 15 Million AUD | 0.0% |
2018 Q4 | 15.34 Million AUD | 0.0% |
2017 Q1 | 18.06 Million AUD | 32.7% |
2017 Q4 | 15.69 Million AUD | 0.0% |
2017 FY | 67.5 Million AUD | 57.74% |
2017 Q3 | 15.69 Million AUD | -13.1% |
2017 Q2 | 18.06 Million AUD | 0.0% |
2016 Q1 | 7.78 Million AUD | 97.8% |
2016 Q4 | 13.6 Million AUD | 0.0% |
2016 Q3 | 13.6 Million AUD | 74.74% |
2016 Q2 | 7.78 Million AUD | 0.0% |
2016 FY | 42.79 Million AUD | 92.65% |
2015 Q1 | 7.16 Million AUD | 21.39% |
2015 FY | 22.21 Million AUD | 3.36% |
2015 Q4 | 3.93 Million AUD | 0.0% |
2015 Q3 | 3.93 Million AUD | -45.08% |
2015 Q2 | 7.16 Million AUD | 0.0% |
2014 Q2 | 4.84 Million AUD | 0.0% |
2014 Q4 | 5.9 Million AUD | 0.0% |
2014 Q3 | 5.9 Million AUD | 22.02% |
2014 Q1 | 4.84 Million AUD | -7.62% |
2014 FY | 21.49 Million AUD | 44.25% |
2013 Q3 | 5.23 Million AUD | 137.08% |
2013 FY | 14.89 Million AUD | 0.0% |
2013 Q1 | 2.21 Million AUD | 0.0% |
2013 Q2 | 2.21 Million AUD | 0.0% |
2013 Q4 | 5.23 Million AUD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
American Medical Technologies Inc. | 3.19 Million USD | -5227.068% |
Ansell Limited | 1.61 Billion USD | 89.501% |
Ansell Limited | 1.61 Billion USD | 89.501% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 184.64 Million USD | 7.926% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 135.05 Thousand USD | -125783.529% |
Psykey, Inc. | 419.29 Thousand USD | -40446.722% |
ConvaTec Group Plc | 2.19 Billion USD | 92.251% |
ConvaTec Group Plc | 2.14 Billion USD | 92.064% |
Encision Inc. | 6.58 Million USD | -2481.461% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 1.82 Million USD | -9216.109% |
LifePoint, Inc. | -18.5 Thousand USD | 919083.784% |
Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -2395.406% |
Paradigm Medical Industries, Inc. | 772 Thousand USD | -21922.28% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 986.22 Thousand USD | -17138.75% |
Reflect Scientific, Inc. | 1.08 Million USD | -15639.608% |
SmileDirectClub, Inc. | 470.74 Million USD | 63.884% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 90.916% |
SheerVision, Inc. | 3.49 Million USD | -4758.309% |
United Health Products, Inc. | - USD | -Infinity% |
Vasamed, Inc. | 1.38 Million USD | -12163.777% |
Wearable Health Solutions, Inc. | 745.09 Thousand USD | -22717.554% |
Yubo International Biotech Limited | 104.28 Thousand USD | -162929.449% |